Teen 'detached from reality' to cope with return of aggressive cancer — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Ethan Griffiths, 14, was diagnosed with Burkitt lymphoma in January, completed chemotherapy and was declared cancer-free in May, then suffered an "aggressive" relapse just two weeks after returning home.
- Bristol Royal Hospital Children enrolled Ethan in a UK-wide clinical trial of two new drugs for B-cell non-Hodgkin lymphoma patients who had not responded to treatment or had relapsed, with the trial offering just a 50% chance of success.
- Ethan's father Lloyd, a lymphoma survivor, advised his son to treat treatment as a journey he couldn't control, telling him "You're a passenger on this journey... you have to kind of keep trying to detach yourself."
- Ethan coped by "sticking earphones in, listening to music and trying to fall asleep" while his father "would be losing his head next to me," and came home cancer-free again in September after intensive chemotherapy and a stem cell transplant using cells collected earlier.
- Ethan is now rebuilding slowly, still getting "really tired just walking," and plans to return to school through online lessons before gradually re-entering the classroom and working back toward rugby.
Why it matters: The 50% odds faced by Ethan underscore how few options exist for pediatric patients whose B-cell non-Hodgkin lymphoma relapses or resists standard treatment, making each successful outcome from this UK-wide trial a meaningful signal for a small but desperate patient group. Lloyd's own cancer experience shaped the family's coping playbook, highlighting how prior patient expertise increasingly guides treatment decisions in trial settings.
Ask SkimNews
